Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

A Review of Drug Side Effect Identification Methods

Author(s): Shuai Deng, Yige Sun, Tianyi Zhao, Yang Hu and Tianyi Zang*

Volume 26, Issue 26, 2020

Page: [3096 - 3104] Pages: 9

DOI: 10.2174/1381612826666200612163819

Price: $65

Abstract

Drug side effects have become an important indicator for evaluating the safety of drugs. There are two main factors in the frequent occurrence of drug safety problems; on the one hand, the clinical understanding of drug side effects is insufficient, leading to frequent adverse drug reactions, while on the other hand, due to the long-term period and complexity of clinical trials, side effects of approved drugs on the market cannot be reported in a timely manner. Therefore, many researchers have focused on developing methods to identify drug side effects. In this review, we summarize the methods of identifying drug side effects and common databases in this field. We classified methods of identifying side effects into four categories: biological experimental, machine learning, text mining and network methods. We point out the key points of each kind of method. In addition, we also explain the advantages and disadvantages of each method. Finally, we propose future research directions.

Keywords: Drug side effect, machine learning, biological experiment, text mining, drug database, experimental.

« Previous Next »
[1]
Ribeiro MR, Motta AA, Marcondes-Fonseca LA, Kalil-Filho J, Giavina-Bianchi P. Increase of 10% in the rate of adverse drug reactions for each drug administered in hospitalized patients. Clinics (São Paulo) 2018. 73e185
[http://dx.doi.org/10.6061/clinics/2018/e185] [PMID: 29451619]
[2]
Osanlou O, Pirmohamed M, Daly AK. Pharmacogenetics of adverse drug reactions. Adv Pharmacol 2018; 83: 155-90.
[http://dx.doi.org/10.1016/bs.apha.2018.03.002] [PMID: 29801574]
[3]
Patton K, Borshoff DC. Adverse drug reactions. Anaesthesia 2018; 73(Suppl. 1): 76-84.
[http://dx.doi.org/10.1111/anae.14143] [PMID: 29313907]
[4]
Realo A, van Middendorp H, Kööts-Ausmees L, Allik J, Evers AWM. Role of personality traits in reporting the development of adverse drug reactions: a prospective cohort study of the Estonian general population. BMJ Open 2018; 8(7)e022428
[http://dx.doi.org/10.1136/bmjopen-2018-022428] [PMID: 29991635]
[5]
Pauwels E, Stoven V, Yamanishi Y. Predicting drug side-effect profiles: a chemical fragment-based approach. BMC Bioinformatics 2011; 12: 169.
[http://dx.doi.org/10.1186/1471-2105-12-169] [PMID: 21586169]
[6]
Gu W, Chen J, Patra P, et al. Nanoformulated water-soluble paclitaxel to enhance drug efficacy and reduce hemolysis side effect. J Biomater Appl 2017; 32(1): 66-73.
[http://dx.doi.org/10.1177/0885328217708458] [PMID: 28504558]
[7]
Guney E. 2017 Investigating side effect modules in the interactome and their use in drug adverse effect discovery. International workshop on complex networks.
[http://dx.doi.org/10.1007/978-3-319-54241-6_21]
[8]
Salehi H, Al-Arag S, Middendrop E, Gergly C, Cuisinier F. Stem cells as anticancer drug carrier to reduce the chemotherapy side effect. In Society of Photo-optical Instrumentation Engineers 2017.
[9]
Molina VB. Personalized drug adverse side effect prediction 2017.
[10]
Hu P, Chan KCC, Lun H, Leung H. Discovering second-order sub-structure associations in drug molecules for side-effect prediction.2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[http://dx.doi.org/10.1109/BIBM.2017.8218013]
[11]
Weinstock C, Khozin S, Suzman D, et al. U.S. food and drug administration approval summary: atezolizumab for metastatic nonsmall cell lung cancer. Clinical Cancer Res: an official journal of the American Association for Cancer Research 2017; 23(16): 4534-39.
[12]
Shen J, Yang J, Zhao B. A survey of the FDA’s adverse event reporting system database concerning urogenital tract infections and sodium glucose cotransporter-2 inhibitor use. Diabetes Ther 2019; 10(3): 1043-50.
[http://dx.doi.org/10.1007/s13300-019-0611-9] [PMID: 30953300]
[13]
Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 2017; 46.
[PMID: 29126136]
[14]
Library WP. Anatomical therapeutic chemical classification system 2015.
[15]
Liu S, Ma W, Moore R, Ganesan V, Nelson S. RxNorm: prescription for electronic drug information exchange. IT Prof 2005; 7: 17-23.
[http://dx.doi.org/10.1109/MITP.2005.122]
[16]
Nahler MPG. COSTART 2009.
[17]
Paulsen CA. Current procedural terminology (CPT). JAMA 1970; 212(5): 873-4.
[http://dx.doi.org/10.1001/jama.1970.03170180149023] [PMID: 4909256]
[18]
Lee S, Han J, Park RW, et al. Development of a controlled vocabulary-based adverse drug reaction signal dictionary for multicenter electronic health record-based pharmacovigilance. Drug Saf 2019; 42(5): 657-70.
[http://dx.doi.org/10.1007/s40264-018-0767-7] [PMID: 30649749]
[19]
Perucca P, Jacoby A, Marson AG, et al. Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology 2011; 76(3): 273-9.
[http://dx.doi.org/10.1212/WNL.0b013e318207b073] [PMID: 21242496]
[20]
Short B, Fong J, Galvez V, Shelker W, Loo CK. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry 2018; 5(1): 65-78.
[http://dx.doi.org/10.1016/S2215-0366(17)30272-9] [PMID: 28757132]
[21]
Haastrup PF, Thompson W, Søndergaard J, Jarbøl DE. Side effects of long-term proton pump inhibitor use: a review. Basic Clin Pharmacol Toxicol 2018; 123(2): 114-21.
[http://dx.doi.org/10.1111/bcpt.13023] [PMID: 29658189]
[22]
Wang SM, Han C, Bahk WM, et al. Addressing the side effects of contemporary antidepressant drugs: a comprehensive review. Chonnam Med J 2018; 54(2): 101-12.
[http://dx.doi.org/10.4068/cmj.2018.54.2.101] [PMID: 29854675]
[23]
Viecelli AK, Irish AB, Polkinghorne KR, et al. Omega-3 polyunsaturated fatty acid supplementation to prevent arteriovenous fistula and graft failure: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 2018; 72(1): 50-61.
[http://dx.doi.org/10.1053/j.ajkd.2017.11.017] [PMID: 29395485]
[24]
Hu Y, Zhao T, Zang T, Zhang Y, Cheng L. Identification of Alzheimer’s disease-related genes based on data integration method. Front Genet 2018; 9.
[PMID: 30740125]
[25]
Cheng L, Hu Y, Sun J, Zhou M, Jiang Q. DincRNA: a comprehensive web-based bioinformatics toolkit for exploring disease associations and ncRNA function. Bioinformatics 2018; 34(11): 1953-6.
[http://dx.doi.org/10.1093/bioinformatics/bty002] [PMID: 29365045]
[26]
Cheng L, Jiang Y, Ju H, et al. InfAcrOnt: calculating cross-ontology term similarities using information flow by a random walk. BMC Genomics 2018; 19(Suppl. 1): 919.
[http://dx.doi.org/10.1186/s12864-017-4338-6] [PMID: 29363423]
[27]
Cheng L, Sun J, Xu W, Dong L, Hu Y, Zhou M. OAHG: an integrated resource for annotating human genes with multi-level ontologies. Sci Rep 2016; 6: 34820.
[http://dx.doi.org/10.1038/srep34820] [PMID: 27703231]
[28]
Pan Y, Wang Z, Zhan W, Deng L. Computational identification of binding energy hot spots in protein-RNA complexes using an ensemble approach. Bioinformatics 2018; 34(9): 1473-80.
[http://dx.doi.org/10.1093/bioinformatics/btx822] [PMID: 29281004]
[29]
Cheng L, Wang P, Tian R, et al. LncRNA2Target v2.0: a comprehensive database for target genes of lncRNAs in human and mouse. Nucleic Acids Res 2019; 47(D1): D140-4.
[http://dx.doi.org/10.1093/nar/gky1051] [PMID: 30380072]
[30]
Cheng L, Yang H, Zhao H, et al. MetSigDis: a manually curated resource for the metabolic signatures of diseases. Brief Bioinform 2019; 20(1): 203-9.
[http://dx.doi.org/10.1093/bib/bbx103] [PMID: 28968812]
[31]
Cheng L, Zhuang H, Yang S, Jiang H, Wang S, Zhang J. Exposing the causal effect of C-reactive protein on the risk of type 2 diabetes mellitus: a mendelian randomization study. Front Genet 2018; 9: 657.
[http://dx.doi.org/10.3389/fgene.2018.00657] [PMID: 30619477]
[32]
Deng L, Wang J, Zhang J. Predicting gene ontology function of human micrornas by integrating multiple networks. Front Genet 2019; 10: 3.
[http://dx.doi.org/10.3389/fgene.2019.00003] [PMID: 30761178]
[33]
Zhang J, Zhang Z, Wang Z, Liu Y, Deng L. Ontological function annotation of long non-coding RNAs through hierarchical multi-label classification. Bioinformatics 2018; 34(10): 1750-7.
[http://dx.doi.org/10.1093/bioinformatics/btx833] [PMID: 29293953]
[34]
Zhang Z, Zhang J, Fan C, Tang Y, Deng L. KATZLGO: large-scale prediction of LncRNA functions by using the KATZ measure based on multiple networks IEEE/ACM Trans Comput Biol Bioinform 2019; 16: 407-416..
[35]
Hu Y, Zhao T, Zhang N, Zhang Y, Cheng L. A review of recent advances and research on drug target identification methods. Curr Drug Metab 2019; 20(3): 209-16.
[http://dx.doi.org/10.2174/1389200219666180925091851] [PMID: 30251599]
[36]
Zhao T, Hu Y, Valsdottir LR, Zang T, Peng J. Identifying drug-target interactions based on graph convolutional network and deep neural network . Brief Bioinform 2020. bbaa044
[http://dx.doi.org/10.1093/bib/bbaa044] [PMID: 32367110]
[37]
Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH. PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res 2009; 37(Web Server issue):: W623-33..
[http://dx.doi.org/10.1093/nar/gkp456] [PMID: 19498078]
[38]
Kuhn M, Szklarczyk D, Franceschini A, von Mering C, Jensen LJ, Bork P. STITCH 3: zooming in on protein-chemical interactions. Nucleic Acids Res 2012; 40(Database issue): D876-80.
[http://dx.doi.org/10.1093/nar/gkr1011] [PMID: 22075997]
[39]
None UniProt: a hub for protein information. Nucleic Acids Research 2015; 43: 204-12.
[40]
Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res 2016; 44(D1): D1075-9.
[http://dx.doi.org/10.1093/nar/gkv1075] [PMID: 26481350]
[41]
Davis AP, Murphy CG, Johnson R, et al. The comparative toxicogenomics database: update 2011. Nucleic Acids Res 2013; 41(Database issue): D1104-14.
[http://dx.doi.org/10.1093/nar/gks994] [PMID: 23093600]
[42]
Kanehisa M. The KEGG database. Novartis Found Symp 2002; 247: 91-101.
[http://dx.doi.org/10.1002/0470857897.ch8] [PMID: 12539951]
[43]
Tetko IV. Computing chemistry on the web. Drug Discov Today 2005; 10(22): 1497-500.
[http://dx.doi.org/10.1016/S1359-6446(05)03584-1] [PMID: 16257371]
[44]
Thanh Noi P, Kappas M. Comparison of random forest, k-nearest neighbor, and support vector machine classifiers for land cover classification using sentinel-2 imagery. Sensors (Basel) 2017; 18(1): 18.
[http://dx.doi.org/10.3390/s18010018] [PMID: 29271909]
[45]
Bobashev GV, Anthony JC. Use of alternating logistic regression in studies of drug-use clustering. Subst Use Misuse 2000; 35(6-8): 1051-73.
[http://dx.doi.org/10.3109/10826080009148432] [PMID: 10847222]
[46]
Peterson LE. K-nearest neighbor. Scholarpedia 2009; 4: 1883.
[http://dx.doi.org/10.4249/scholarpedia.1883]
[47]
Witten DM, Tibshirani RJ. Extensions of sparse canonical correlation analysis with applications to genomic data. Stat Appl Genet Mol Biol 2009; 8e28
[http://dx.doi.org/10.2202/1544-6115.1470] [PMID: 19572827]
[48]
Li T, Li J, Liu Z, Li P, Jia C. Differentially private naive bayes learning over multiple data sources. Inf Sci 2018; 444: 89-104.
[http://dx.doi.org/10.1016/j.ins.2018.02.056]
[49]
Riddick G, Song H, Ahn S, et al. Predicting in vitro drug sensitivity using Random Forests. Bioinformatics 2011; 27(2): 220-4.
[http://dx.doi.org/10.1093/bioinformatics/btq628] [PMID: 21134890]
[50]
Martarelli D, Casettari L, Shalaby KS, et al. Melatonin; ANN; drug delivery; hydrophilic polymers; similarity fit factors; tablet formulation. Current Drug Delivery 2015; 12.
[51]
Huang LC, Wu X, Chen JY. Predicting adverse side effects of drugs. BMC Genomics 2011; 12(Suppl. 5): S11.
[http://dx.doi.org/10.1186/1471-2164-12-S5-S11] [PMID: 22369493]
[52]
Mizutani S, Pauwels E, Stoven V, Goto S, Yamanishi Y. Relating drug-protein interaction network with drug side effects. Bioinformatics 2012; 28(18): i522-8.
[http://dx.doi.org/10.1093/bioinformatics/bts383] [PMID: 22962476]
[53]
Liu M, Cai R, Hu Y, et al. Determining molecular predictors of adverse drug reactions with causality analysis based on structure learning. J Am Med Inform Assoc 2014; 21(2): 245-51.
[http://dx.doi.org/10.1136/amiajnl-2013-002051] [PMID: 24334612]
[54]
Bresso E, Grisoni R, Marchetti G, et al. Integrative relational machine-learning for understanding drug side-effect profiles. BMC Bioinformatics 2013; 14: 207-7.
[http://dx.doi.org/10.1186/1471-2105-14-207] [PMID: 23802887]
[55]
Jahid MJ, Ruan J. An ensemble approach for drug side effect prediction. IEEE International Conference on Bioinformatics & Biomedicine.
[http://dx.doi.org/10.1109/BIBM.2013.6732532]
[56]
Zhang W, Liu F, Luo L, Zhang J. Predicting drug side effects by multi-label learning and ensemble learning. BMC Bioinformatics 2015; 16: 365.
[http://dx.doi.org/10.1186/s12859-015-0774-y] [PMID: 26537615]
[57]
Niu SY, Xin MY, Luo J, Liu MY, Jiang ZR. DSEP: A tool implementing novel method to predict side effects of drugs. J Comput Biol 2015; 22(12): 1108-17.
[http://dx.doi.org/10.1089/cmb.2015.0129] [PMID: 26484391]
[58]
Pandey C, Ibrahim Z, Wu H, Iqbal E, Dobson R. improving rnn with attention and embedding for adverse drug reactions. International Conference on Digital Health.
[http://dx.doi.org/10.1145/3079452.3079501]
[59]
Cocos A, Fiks AG, Masino AJ. Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts. J Am Med Inform Assoc 2017; 24(4): 813-21.
[http://dx.doi.org/10.1093/jamia/ocw180] [PMID: 28339747]
[60]
Dey S, Luo H, Fokoue A, Hu J, Zhang P. Predicting adverse drug reactions through interpretable deep learning framework. BMC Bioinformatics 2018; 19(Suppl. 21): 476.
[http://dx.doi.org/10.1186/s12859-018-2544-0] [PMID: 30591036]
[61]
Trick WE, Chapman WW, Wisniewski MF, et al. Electronic interpretation of chest radiograph reports to detect central venous catheters. Infect Control Hosp Epidemiol 2003; 24(12): 950-4.
[http://dx.doi.org/10.1086/502165] [PMID: 14700412]
[62]
Seoud RAA, Youssef ABM, Kadah YM. Extraction of protein interaction information from unstructured text using a link grammar parser. International Conference on Computer Engineering & Systems.
[63]
Arnold T, Tilton L. coreNLP: Wrappers around Stanford CoreNLP Tools 2016.
[64]
Loper E, Bird S. NLTK: The Natural Language Toolkit 2002.
[65]
Cheng L, Qi C, Zhuang H, Fu T, Zhang X. gutMDisorder: a comprehensive database for dysbiosis of the gut microbiota in disorders and interventions. Nucleic Acids Res 2019; 48: D554-60.
[PMID: 31584099]
[66]
Xu R, Wang Q. Automatic construction of a large-scale and accurate drug-side-effect association knowledge base from biomedical literature. J Biomed Inform 2014; 51: 191-9.
[http://dx.doi.org/10.1016/j.jbi.2014.05.013] [PMID: 24928448]
[67]
Coloma PM, Schuemie MJ, Trifirò G, et al. EU-ADR Consortium. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf 2011; 20(1): 1-11.
[http://dx.doi.org/10.1002/pds.2053] [PMID: 21182150]
[68]
Krallinger M, Morgan A, Smith L, et al. Evaluation of text-mining systems for biology: overview of the Second BioCreative community challenge. Genome Biol 2008; 9(Suppl. 2): S1-1.
[http://dx.doi.org/10.1186/gb-2008-9-s2-s1] [PMID: 18834487]
[69]
Cherry C, Zhu X, Martin J, de Bruijn B. A la Recherche du Temps Perdu: extracting temporal relations from medical text in the 2012 i2b2 NLP challenge. J Am Med Inform Assoc 2013; 20(5): 843-8.
[http://dx.doi.org/10.1136/amiajnl-2013-001624] [PMID: 23523875]
[70]
Peng J, Hui W, Li Q, et al. A learning-based framework for miRNA-disease association identification using neural networks. Bioinformatics 2019; 35(21): 4364-71.
[http://dx.doi.org/10.1093/bioinformatics/btz254] [PMID: 30977780]
[71]
Hu Y, Zhao T, Zhang N, Zang T, Zhang J, Cheng L. Identifying diseases-related metabolites using random walk. BMC Bioinformatics 2018; 19(Suppl. 5): 116.
[http://dx.doi.org/10.1186/s12859-018-2098-1] [PMID: 29671398]
[72]
Peng J, Wang X, Shang X. Combining gene ontology with deep neural networks to enhance the clustering of single cell RNA-Seq data. BMC Bioinformatics 2019; 20(Suppl. 8): 284.
[http://dx.doi.org/10.1186/s12859-019-2769-6] [PMID: 31182005]
[73]
Peng J, Guan J, Shang X. Predicting Parkinson’s disease genes based on node2vec and autoencoder. Front Genet 2019; 10: 226.
[http://dx.doi.org/10.3389/fgene.2019.00226] [PMID: 31001311]
[74]
Keiser MJ, Setola V, Irwin JJ, et al. Predicting new molecular targets for known drugs. Nature 2009; 462(7270): 175-81.
[http://dx.doi.org/10.1038/nature08506] [PMID: 19881490]
[75]
Lee S, Lee KH, Song M, Lee D. Building the process-drug-side effect network to discover the relationship between biological processes and side effects. BMC Bioinformatics 2011; 12(Suppl. 2): S2-2.
[http://dx.doi.org/10.1186/1471-2105-12-S2-S2] [PMID: 21489221]
[76]
Ali YEM, Heong KK, Ratnavelu K. Predicting new drug indications from network analysis. Int J Mod Phys C 2017; 28: 1.
[77]
Zhang Y, Liu Y, Su Y, et al. The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis. BMC Psychiatry 2017; 17(1): 373.
[http://dx.doi.org/10.1186/s12888-017-1539-0] [PMID: 29162032]
[78]
Takeda T, Hao M, Cheng T, Bryant SH, Wang Y. Predicting drug-drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge. J Cheminform 2017; 9: 16.
[http://dx.doi.org/10.1186/s13321-017-0200-8] [PMID: 28316654]
[79]
Zitnik M, Agrawal M, Leskovec J. Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics 2018; 34(13): i457-66.
[http://dx.doi.org/10.1093/bioinformatics/bty294] [PMID: 29949996]

Rights & Permissions Print Cite
Article Metrics
65
3
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy